RECRUITINGPhase 3INTERVENTIONAL
VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma
VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma (VICTORY)
About This Trial
The overall aim of the study is to develop a nutritional preventive vitamin D supplementation strategy in pregnancy for early childhood asthma/persistent wheeze during the first three years of life as we hypothesize that supplementation in higher doses than recommended could reduce the risk of disease development.
Who May Be Eligible (Plain English)
* Pregnant Danish women before week 26 with blood levels of EPA+DHA above 4.7% of total fatty acids
- No current vitamin D intake above the recommended 400 IU/day
- No endocrine-, heart-, kidney- or auto-immune disorders
- No disorders requiring treatment with blood thinning medication
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
* Pregnant Danish women before week 26 with blood levels of EPA+DHA above 4.7% of total fatty acids
* No current vitamin D intake above the recommended 400 IU/day
* No endocrine-, heart-, kidney- or auto-immune disorders
* No disorders requiring treatment with blood thinning medication
Treatments Being Tested
DIETARY_SUPPLEMENT
Cholecalciferol D3
Oral intake of 1 capsule per day from week 22-26 in pregnancy to 1 week after delivery
OTHER
Olive oil
Oral intake of 1 capsule per day from week 22-26 in pregnancy to 1 week after delivery
Locations (1)
Copenhagen University Hospital of Copenhagen
Gentofte Municipality, Denmark